GLENMARK LIFE SCIENCES
Back to Balance Sheet
|
GLENMARK LIFE SCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹49 Cr | ₹42 Cr | ₹31 Cr | ₹23 Cr | ₹16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK LIFE SCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹49 Cr |
Mar2023 | ₹42 Cr |
Mar2022 | ₹31 Cr |
Mar2021 | ₹23 Cr |
Mar2020 | ₹16 Cr |
How is Deferred Tax Assets / Liabilities of GLENMARK LIFE SCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹49 Cr | 14.97 | |
Mar2023 | ₹42 Cr | 34.73 | |
Mar2022 | ₹31 Cr | 37.60 | |
Mar2021 | ₹23 Cr | 39.15 | |
Mar2020 | ₹16 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹15,144.7 Cr | 2.1% | 17.8% | 39.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,384.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | 2.1% |
17.8% |
39.2% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses